Inspire Veterinary에 대한 매도 수량은 투자자에게 Inspire Veterinary의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Inspire Veterinary (NASDAQ:IVP) 주식, 공매도 수량 보고

Inspire Veterinary

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Exclusives

Tech

Trading Ideas

ETFs

AAPL

AMZN

CRWD

KOSS

LGVN

MIRA

MSFT

NUZE

NVDA

PLTR

SERV

SMCI

SOBR

TSLA

ZAPP

각 거래일에는 트레이더들이 전체 시장과 개별 종목들에 대한 최신 뉴스를 볼 수 있는 소스의 하나인 Benzinga Pro에 수백 개의 헤드라인과 보도 자료가 제공된다. 2024년 7월 한 달 동안 Benzinga Pro에서 가장 많이 검색된 주식을 살펴보겠다. 현재 가격과 연간 실적은 8월 1일을 기준으로 하며 배당금은 포함되지 않는다. 4월 검색결과는 추적되지 않았다.

단독: 7월 벤징가 프로에서 가장 많이 검색된 상위 20개 종목 - 테슬라, 엔비디아, CRWD 순위는?

Inspire Veterinary Partners, Inc. - Class A Common Stock

Inspire Veterinary Partners Inc

IVANHOE MINES LTD A by Ivanhoe Mines Ltd.

Ivanhoe Mines Ltd

Mizuho analyst Ben Chaiken reiterates Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Outperform and lowers the price target from $255 to $253.

News

Price Target

Reiteration

Analyst Ratings

Mizuho Reiterates Outperform on Royal Caribbean Gr, Lowers Price Target to $253

Dime Community Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCOM#NASDAQ">DCOM</a>) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.45 by 6.67 percent. This is a 7.69 percent increase over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $57.237 million which missed the analyst consensus estimate of $88.210 million by 35.11 percent. This is a 31.03 percent decrease over sales of $82.993 million the same period last year.

Earnings

Earnings Misses

DCOM

Dime Community Bancshares Q4 2024 Adj. EPS $0.42 Misses $0.45 Estimate, Sales $57.237M Miss $88.210M Estimate

HC Wainwright &amp; Co. analyst Robert Burns maintains Nuvation Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUVB#NYSE">NUVB</a>) with a Buy and raises the price target from $10 to $11.

NUVB

HC Wainwright & Co. Maintains Buy on Nuvation Bio, Raises Price Target to $11

Roth MKM analyst Chip Moore initiates coverage on Innventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) with a Buy rating and announces Price Target of $16.

Initiation

Roth MKM Initiates Coverage On Innventure with Buy Rating, Announces Price Target of $16

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies analyst Stephanie Moore downgraded the rating for Casella Waste Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWST#NASDAQ">CWST</a>) from Buy to Hold and lowered the price target from $115 to $113. Casella Waste shares closed at $107.83 on Wednesday. <a href="https://www.benzinga.com/quote/CWST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Matthew Boss downgraded Acushnet Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>) from Neutral to Underweight and announced a $64 price target. Acushnet shares closed at $74.60 on Wednesday. <a href="https://www.benzinga.com/quote/GOLF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Brian Pitz downgraded the rating for Electronic Arts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) from Outperform to Market Perform and lowered the price target from $160 to $145. Electronic Arts shares closed at $142.35 on Wednesday. <a href="https://www.benzinga.com/quote/EA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Gabriela Borges downgraded Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) from Buy to Sell and lowered the price target from $261 to $200. Veeva Systems shares closed at $229.07 on Wednesday. <a href="https://www.benzinga.com/quote/VEEV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Michael Lavery downgraded the rating for The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) from Overweight to Neutral and slashed the price target from $370 to $275. Boston Beer shares closed at $250.19 on Wednesday. <a href="https://www.benzinga.com/quote/SAM/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying EA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23071606/image-167-1024x552.png" alt="" class="wp-image-746619" style="width:536px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23071606/image-167-1024x552.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23071606/image-167-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23071606/image-167-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23071606/image-167.png 1136w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Downgrades

Pre-Market Outlook

Markets

CWST

GOLF

VEEV

This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Contracts

SES AI Secures Contracts Totaling Up To $10M With Two Existing Major Global OEM Partners

Biotech

Health Care

General

TRAW

Traws Pharma Announced Completion Of Phase 1 Clinical Studies Of Its Investigational One-dose Influenza Therapy, Tivoxavir Marboxil (Tivoxavir), For The Treatment Or Prevention Of H5N1 Bird Flu.

PLUR

Pluri shares are trading higher after the company announced a private placement and the acquisition of a 71% stake in Kokomodo.

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) with a Buy and maintains $16 price target.

ESPR

HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target

Pluri Announces $6.5M Private Placement With Investor Alejandro Weinstein; Co. Will Purchase ~71% Of Kokomodo's Shares

WIIM

Shares of airline stocks are trading lower following weak guidance from American Airlines.

BEAM

Beam Therapeutics To Encore Data From BEACON Phase 1/2 Clinical Trial Of BEAM-101 In Sickle Cell Disease At Tandem Meetings Of ASTCT And CIBMTR

Raymond James analyst Steve Moss upgrades First Community (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCCO#NASDAQ">FCCO</a>) from Outperform to Strong Buy and raises the price target from $27 to $30.

Upgrades

FCCO

Raymond James Upgrades First Community to Strong Buy, Raises Price Target to $30

On Wednesday, January 22, U.S. markets closed higher, with the S&amp;P 500 reaching a record high as Netflix gained significantly after reporting record subscribers and announcing price increases. Technology stocks, driven by AI leaders like Nvidia and Microsoft, led gains. Despite unclear funding details, investors were optimistic about President Trump&#8217;s private-sector AI investment plan.
In economic data, U.S. mortgage applications increased slightly from the prior week during the week ending January 17.
Most S&amp;P 500 sectors declined, but information technology and communication services stocks closed higher, defying the overall trend.
The Dow Jones Industrial Average was up 0.30% and closed at 44,156.73, the S&amp;P 500 closed higher by 0.61% at 6,086.37, and the Nasdaq Composite rose 1.28% to finish at 20,009.34.
Aisa Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 closed higher by 0.98% at 40,003.50, led by gains in the Precision Instruments, Communication, and Non-Metal Minerals sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 declined 0.61%, ending the session at 8,378.70, led by losses in the Metals &amp; Mining, Consumer Discretionary, and Materials sectors.</li>
<li>India&#8217;s Nifty 50 closed higher by 0.25% at 23,213.75, and the Nifty 500 rose 0.65%, closing at 21,536.10, led by gains in the Consumer Durables, Real Estate, and Technology sectors.</li>
<li>China&#8217;s Shanghai Composite gained 0.51% and closed at 3,230.16, and the Shenzhen CSI 300 rose 0.18%, finishing the day at 3,803.74.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.40% at 19,700.56.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was down 0.06%.</li>
<li>Germany&#8217;s DAX rose 0.24%.</li>
<li>France&#8217;s CAC was up 0.23%.</li>
<li>U.K.&#8217;s FTSE index 100 traded lower by 0.06%.</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.19% at $75.31/bbl, and Brent was down 0.14% at $78.91/bbl.</li>
<li>Oil prices remained steady, weighed down by uncertainty over U.S. tariffs, energy policies, and rising crude inventories.</li>
<li>Natural Gas declined 0.45% to $3.942.</li>
<li>Gold was trading lower by 0.54% at $2,756.10, Silver was down 1.00% to $31.105, and Copper fell 0.42% to $4.2380.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures were up 0.05%, S&amp;P 500 futures fell 0.17% and Nasdaq 100 futures declined 0.49%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. Dollar Index declined 0.07% to 108.18, USD/JPY fell 0.11% to 156.32, and USD/AUD gained 0.07% to 1.5951.</li>
<li>The dollar traded within tight ranges on Thursday, lacking direction amid uncertainty over President Trump&#8217;s U.S. tariff announcements.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Equities

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Dollar Index Ticks Lower - Global Markets Today While US Slept

"Under the terms of the MOU, IonQ plans to provide quantum computing cloud services, support the planning and execution of joint quantum initiatives, and contribute to the workforce and economic development of South Korea. In turn, the Busan Metropolitan Government will help create an environment conducive to the growth of the quantum technology sector."

IONQ

IonQ Signs MoU With The Busan Metropolitan Government in South Korea; Co. Plans To Provide Quantum Computing Cloud Services And Support Quantum Initiatives

The investment marks an important milestone in Visa's commitment to advancing financial inclusion and shaping the future of digital payments while fostering SME growth across Africa.

Nigeria's Moniepoint Secures Investment From Visa; No Terms Disclosed

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) with a Buy and raises the price target from $4 to $6.

PGEN

HC Wainwright & Co. Reiterates Buy on Precigen, Raises Price Target to $6

CLST

Catalyst Bancorp Q4 2024 GAAP EPS $0.16 Up From $0.08 YoY, Sales $2.81M Up From $2.63M YoY

Raymond James analyst Andrew Marok downgrades Electronic Arts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) from Outperform to Market Perform.

Raymond James Downgrades Electronic Arts to Market Perform

Veeva, Zifo Announce Product Partnership To Help Biopharmas Modernize Quality Control Operations

An update from Inspire Veterinary Partners, Inc. Class A (IVP) is now available. Kimball Carr's tenure as Chief Executive Officer has been extended...

Inspire Veterinary Partners CEO Tenure Extended, New Steering Committee Formed

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Inspire Veterinary (NASDAQ:<a href="https://investorplace.com/stock-quotes/ivp-stock-quote/">IVP</a>) just reported results for the second quarter of 2024.<ul><li>Inspire Veterinary reported earnings per share of -70 cents.</li><li>The company reported revenue of $4.39 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ivp-stock-earnings-inspire-veterinary-for-q2-of-2024/">IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

IVP Stock Earnings: Inspire Veterinary Reported Results for Q2 2024

Inspire Veterinary Partners GAAP EPS of -$0.70, revenue of $4.4M

Inspire Veterinary Partners to acquire Vetsie.ai

Inspire Veterinary Partners files $100M mixed shelf offering

Inspire Veterinary stock higher as it looks to raise $2.5M through direct offering

Inspire Veterinary (IVP) Partners has entered into a securities purchase agreement with institutional investors, providing for the purchase and sal...

Inspire Veterinary to sell 10M shares at 25c in registered direct offering

Inspire Veterinary Partners GAAP EPS of -$0.38, revenue of $4.05M

Inspire Veterinary (IVP) announced that it will effect a 1-for-25 reverse stock split of its authorized and issued and outstanding shares of Class ...

Inspire Veterinary announces 1-for-25 reverse stock split

Inspire Veterinary Partners announces 1-for-25 reverse stock split to regain NASDAQ compliance

Screenshot 2024-02-27 at 6.34.08 PM

CHWY

FRPT

More Millennials Are Opting For Pets Over Children As Pet Industry Continues To Grow

Press Releases

Inspire Veterinary Partners Reaffirms Plans to Accelerate Acquisition and Growth Strategy Following Closing of Recent Public Offering

Inspire Veterinary Partners Reports Second Quarter 2024 Financial Results

Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

Inspire Veterinary Partners Unveils Plans for New Verticals to Drive Next Phase of Growth in Veterinary Care

Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

Inspire Veterinary Partners Announces $2.5 Million Registered Direct Offering of Common Stock

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

Comments

Inspire Veterinary

매도 수량

Inspire Veterinary (NASDAQ:IVP) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌